Minimising moxifloxacin resistance with tuberculosis

Lancet Infect Dis. 2008 May;8(5):273-5. doi: 10.1016/S1473-3099(08)70077-X.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antitubercular Agents / pharmacology*
  • Aza Compounds / pharmacology*
  • Colony Count, Microbial
  • Drug Resistance, Bacterial*
  • Drug Resistance, Multiple, Bacterial
  • Fluoroquinolones
  • Humans
  • Microbial Sensitivity Tests
  • Moxifloxacin
  • Mycobacterium tuberculosis / drug effects*
  • Quinolines / pharmacology*
  • Sentinel Surveillance
  • Tuberculosis / drug therapy*
  • Tuberculosis / microbiology

Substances

  • Antitubercular Agents
  • Aza Compounds
  • Fluoroquinolones
  • Quinolines
  • Moxifloxacin